Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Lymphoma, Mantle-Cell × tocilizumab × Clear all

Phase

Phase 2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 2 Lymphoma, Non-Hodgkin 2 Leukemia 2 Hematologic Neoplasms 2 Urinary Bladder Neoplasms 1 Urethral Neoplasms 1 Ureteral Neoplasms 1 Unresectable Pancreatic Carcinoma 1 Sarcoma, Kaposi 1 Respiratory Tract Infections 1 Respiratory Distress Syndrome 1 Prostatic Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pneumonia 1 Pancreatic Neoplasms 1 Neoplasms 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Multi-centric Castleman's Disease 1 Lymphoma, Mantle-Cell 1 Lung Neoplasms 1 Leukemia, Myeloid, Acute 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Immune-related Adverse Events 1 Hodgkin Disease 1 Head and Neck Neoplasms 1 Graft vs Host Disease 1 Glioblastoma 1

Interventions

Rituximab 107 Cyclophosphamide 95 fludarabine phosphate 45 Peripheral Blood Stem Cell Transplantation 44 Cytarabine 43 Etoposide 39 Mycophenolic Acid 37 Filgrastim 36 Whole-Body Irradiation 34 Bortezomib 32 Tacrolimus 31 Methotrexate 31 Melphalan 29 Cyclosporine 29 Radiotherapy 28 Vincristine 27 Busulfan 27 Doxorubicin 26 Dexamethasone 26 Antilymphocyte Serum 23 Carmustine 22 Bendamustine Hydrochloride 22 Lenalidomide 21 ibrutinib 20 Granulocyte Colony-Stimulating Factor 17 fludarabine 16 Prednisone 16 zanubrutinib 15 venetoclax 15 obinutuzumab 15

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05833763 2024-01-08

GOlDiLOX

Australasian Leukaemia and Lymphoma Group

Phase 2 Recruiting

Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡